PYC Therapeutics Limited (ASX:PYC) shares closed at AUD 2.20, up 2.33% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s RNA therapeutics pipeline, clinical progress and financial position.
Regis Healthcare Limited (ASX:REG) shares closed at AUD 6.38, up 1.59% on 20 August 2026. The movement reflects a positiveTrading sessionas investors continue to assess the company’s aged care platform, operational performance and sector-wide funding developments.
Ryman Healthcare Limited (ASX:RYM) shares closed at AUD 1.76, up 0.86% on 20 August 2026. The movement reflects a slightly positiveTrading sessionas investors continue to assess the company’s operational reset, retirement living strategy and aged care performance.
Summerset Group Holdings Limited (ASX:SNZ) shares closed at AUD 6.58, down 1.35% on 20 August 2026. The movement reflects a weakerTrading sessionas investors continue to assess the company’s retirement village model, development pipeline and operating conditions across New Zealand and Australia.
Underlying groupRevenueincreased 2.1% to $1.373 billion, while underlying EBITDA rose 8.1% to $258.6 million. Underlying EBIT increased 76.6% to $30.2 million, compared with $17.1 million a year earlier.
The headline event of the June quarter was a contracted US$500,000 payment from Provider Network Solutions (PNS), the Florida-based managed services organisation that has become Singular Health’s anchor US customer. The payment flowed under a binding enterprise agreement first struck in mid-2025 and followed …
The FY26 numbers, covering the year to 30 June 2026, showed revenue up 22.9 per cent on a reported basis, or 28.4 per cent in constant currency once the stronger Australian dollar is stripped out. Underlying NPAT rose 24.1 per cent to $144.7 million. …
For the fourth quarter to 30 June, ResMed (ASX:RMD) reported revenue of US$1.464 billion, up 9 per cent (8 per cent in constant currency). Full-year revenue reached US$5.653 billion, a 10 per cent gain. Full-yearGAAPOperating Incomewas US$1.887 billion andNet IncomeUS$1.523 billion. StatutoryDiluted Earnings per …
Medibank (ASX: MPL) slipped 8.45% lower to $4.60 AUD today despite health segment profit growth, as rising costs andMarginpressure weighed on sentiment. Investors remain cautious about near-termEarningsmomentum. The company reported higher revenue and profit for FY26, with growth acrossHealth Insuranceand Medibank Health contributing to …
Medical Developments International Limited (ASX:MVP) reported FY26 revenue of $42.6 million, an increase of 9% from $39.1 million a year earlier, as higher Pain Management sales offset weaker Respiratory revenue. Net profit after tax increased to $0.6 million from $0.1 million, while EBIT improved …